Pacer Advisors, Inc.

Position in KRYS — Krystal Biotech, Inc.

CIK 1616667 Malvern, PA

Position in KRYS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$488,746

-$169,195 QoQ

Shares Held

1,315

-48.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#249

of 419 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Pacer Advisors, Inc. holds $626,865,233 across 140 Biotechnology names. KRYS ranks #19 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	369,451	$230,367,476
2	INCY	Incyte Corp	1,431,426	$162,266,451
3	EXEL	Exelixis, Inc.	1,096,682	$59,670,467
4	VRTX	Vertex Pharmaceuticals Inc / Ma	72,465	$35,995,539
5	JAZZ	Jazz Pharmaceuticals plc	146,264	$35,245,236
6	BMRN	Biomarin Pharmaceutical Inc	506,545	$28,984,504
7	HALO	Halozyme Therapeutics, Inc.	228,060	$17,850,256
8	HRMY	Harmony Biosciences Holdings, Inc.	348,239	$12,679,381

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$488,746	1,315	-48.4%	Shares	Sole	2026-08-13
2026-03-31	$657,941	2,547	+319.6%	Shares	Sole	2026-06-18
2025-09-30	$107,153	607	+33.4%	Shares	Sole	2025-10-15
2025-06-30	$62,544	455	-35.7%	Shares	Sole	2025-08-12
2025-03-31	$127,652	708	-49.4%	Shares	Sole	2025-05-06
2024-12-31	$219,324	1,400	+488.2%	Shares	Sole	2025-01-22
2024-06-30	$43,706	238	-5.6%	Shares	Sole	2024-08-13
2024-03-31	$44,838	252	-58.1%	Shares	Sole	2024-05-10
2021-03-31	$46,378	602	-1.0%	Shares	Sole	2021-04-05
2020-12-31	$36,480	608	-28.3%	Shares	Sole	2021-01-20
2020-09-30	$36,506	848	—	Shares	Sole	2020-10-19
No filing history on record for this holder in this stock.